Evidence map›Paper›PMID 26717550›Full record

ArticleJournal of neurochemistry2016

Nicastrin is required for amyloid precursor protein (APP) but not Notch processing, while anterior pharynx-defective 1 is dispensable for processing of both APP and Notch.

Chen Hu, Linlin Zeng, Ting Li, Michael A Meyer, Mei-Zhen Cui, Xuemin Xu

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Neurology international · 2020
    Article
  7. Article
  8. Article
  9. Pen-2 and Presenilin are Sufficient to Catalyze Notch Processing.Journal of Alzheimer's disease : JAD · 2017
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Chen HuDepartment of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.
Linlin ZengSchool of Life Sciences, Jilin University, Changchun, China.
Ting LiDepartment of Cell Biology, Tianjin Medical University, Tianjin, China.
Michael A MeyerSisters Hospital, Buffalo, New York, USA.
Mei-Zhen CuiDepartment of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.
Xuemin XuDepartment of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA.
Knoxville College · USJilin University · CNSisters of Charity Hospital · USTianjin Medical University · CN

Funding

Novel mechanism mediating LPA-induced smooth muscle cell and vascular responsesR01HL107466 · NHLBI · UNIVERSITY OF TEXAS OF THE PERMIAN BASIN · PI CUI, MEI-ZHEN · 2011 to 2020
$3.3M
The role of the new zeta-cleavage in Abeta formationR01AG026640 · NIA · UNIVERSITY OF TENNESSEE KNOXVILLE · PI XU, XUEMIN · 2007 to 2011
$1.4M
Role of A Novel Protein, PSAP, in NeurodegenerationR01NS042314 · NINDS · UNIVERSITY OF TENNESSEE KNOXVILLE · PI XU, XUEMIN · 2001 to 2004
$1.3M
Lysophosphatidic acid &tissue factor in atherosclerosisR01HL074341 · NHLBI · UNIVERSITY OF TENNESSEE KNOXVILLE · PI CUI, MEI-ZHEN · 2004 to 2007
$983k
Pathogenic ROle of the Novel Mitochondrial Apoptotic PSAP in ALSR21NS095256 · NINDS · UNIVERSITY OF TEXAS OF THE PERMIAN BASIN · PI CUI, MEI-ZHEN · 2016 to 2017
$404k
Role of Presenilin Associated Protein (PSAP) in Apoptosis and in Abeta FormationR21AG039596 · NIA · UNIVERSITY OF TENNESSEE KNOXVILLE · PI XU, XUEMIN · 2011 to 2012
$329k
NHLBI NIH HHS R01 HL074341NHLBI NIH HHS R01 HL107466NIA NIH HHS R01 AG026640NIA NIH HHS R21 AG039596NINDS NIH HHS R01 NS042314NINDS NIH HHS R21 NS095256
6 · The paper itself

Abstract

The γ-secretase complex is composed of at least four components: presenilin 1 or presenilin-2, nicastrin (NCT), anterior pharynx-defective 1 (Aph-1), and presenilin enhancer 2. In this study, using knockout cell lines, our data demonstrated that knockout of NCT, as well as knockout of presenilin enhancer 2, completely blocked γ-secretase-catalyzed processing of C-terminal fragment (CTF)α and CTFβ, the C-terminal fragments of β-amyloid precursor protein (APP) produced by α-secretase and β-secretase cleavages, respectively. Interestingly, in Aph-1-knockout cells, CTFα and CTFβ were still processed by γ-secretase, indicating Aph-1 is dispensable for APP processing. Furthermore, our results indicate that Aph-1 as well as NCT is not absolutely required for Notch processing, suggesting that NCT is differentially required for APP and Notch processing. In addition, our data revealed that components of the γ-secretase complex are also important for proteasome- and lysosome-dependent degradation of APP and that endogenous APP is mostly degraded by lysosome while exogenous APP is mainly degraded by proteasome. There are unanswered questions regarding the roles of each component of the γ-secretase complex in amyloid precursor protein (APP) and Notch processing. The most relevant, novel finding of this study is that nicastrin (NCT) is required for APP but not Notch processing, while Aph-1 is not essential for processing of both APP and Notch, suggesting NCT as a therapeutic target to restrict Aβ formation without impairing Notch signaling.

Indexed as

Alzheimer's diseaseAph-1APPgamma-secretasenicastrin

Identifiers

PMID26717550
PMCPMC4929055
OpenAlexW2260880047

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.